| Date Filed | Type | Description |
| 06/15/2023 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $53.08, valued at
$796.2k
|
|
| 05/26/2023 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 21,567 options to buy
@ $1, valued at
$21.6k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 67,000 options to buy
@ $14.77, valued at
$989.6k
|
|
| 10/29/2021 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 30,000 options to buy
@ $22.02, valued at
$660.6k
|
|
| 10/29/2021 |
3
| Kamarck Michael E. (Director) has filed a Form 3 on Vaxcyte, Inc. |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/10/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/08/2016 |
3
| Kamarck Michael E. (Director) has filed a Form 3 on Unilife Corp |
| 02/04/2013 |
4
| Kamarck Michael E. (Director) has filed a Form 4 on OMNI BIO PHARMACEUTICAL, INC.|
Txns:
| Granted 250,000 warrants
@ $0.3, valued at
$75k
|
|
| 10/19/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/29/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 03/03/2009 |
4
| Kamarck Michael E. (President, TO&PS) has filed a Form 4 on WYETH |